Dimension Therapeutics, Inc. Repayments of Notes Payable
Dimension Therapeutics, Inc. reported Repayments of Notes Payable of $1.75 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfNotesPayable · last filed 2017-11-06
- Dimension Therapeutics, Inc. repayments of notes payable for the quarter ending 2017-09-30 was $630.00K, a 331.51% increase year-over-year.
- Dimension Therapeutics, Inc. repayments of notes payable for the quarter ending 2017-06-30 was $629.00K, a 330.82% increase year-over-year.
- Dimension Therapeutics, Inc. repayments of notes payable for the quarter ending 2017-03-31 was $491.00K, a 238.62% increase year-over-year.
- Dimension Therapeutics, Inc. repayments of notes payable for the quarter ending 2016-12-31 was $242.00K, a 65.75% increase year-over-year.
- Dimension Therapeutics, Inc. repayments of notes payable for fiscal 2016 was $679.00K, a 72.34% increase from fiscal 2015.
- Dimension Therapeutics, Inc. repayments of notes payable for fiscal 2015 was $394.00K.
- Dimension Therapeutics, Inc. repayments of notes payable for fiscal 2014 was $0.00.
| Period end | Repayments of Notes Payable 3 month | Repayments of Notes Payable 6 month | Repayments of Notes Payable 9 month | Repayments of Notes Payable 12 month |
|---|---|---|---|---|
| 2017-09-30 | $630.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $1.26M derived: sum of 2 quarters · filed 2017-11-06 | $1.75M 10-Q · filed 2017-11-06 | $1.99M derived: sum of 4 quarters · filed 2017-11-06 |
| 2017-06-30 | $629.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $1.12M 10-Q · filed 2017-08-08 | $1.36M derived: sum of 3 quarters · filed 2017-08-08 | $1.51M derived: sum of 4 quarters · filed 2017-11-06 |
| 2017-03-31 | $491.00K 10-Q · filed 2017-05-10 | $733.00K derived: sum of 2 quarters · filed 2017-05-10 | $879.00K derived: sum of 3 quarters · filed 2017-11-06 | $1.02M derived: sum of 4 quarters · filed 2017-11-06 |
| 2016-12-31 | $242.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $388.00K derived: sum of 2 quarters · filed 2017-11-06 | $534.00K derived: sum of 3 quarters · filed 2017-11-06 | $679.00K 10-K · filed 2017-03-09 |
| 2016-09-30 | $146.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $292.00K derived: sum of 2 quarters · filed 2017-11-06 | $437.00K 10-Q · filed 2017-11-06 | $583.00K derived: sum of 4 quarters · filed 2017-11-06 |
| 2016-06-30 | $146.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $291.00K 10-Q · filed 2017-08-08 | $437.00K derived: sum of 3 quarters · filed 2017-08-08 | $577.00K derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | $145.00K 10-Q · filed 2017-05-10 | $291.00K derived: sum of 2 quarters · filed 2017-05-10 | $431.00K derived: sum of 3 quarters · filed 2017-05-10 | |
| 2015-12-31 | $146.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $286.00K derived: sum of 2 quarters · filed 2017-03-09 | $394.00K 10-K · filed 2017-03-09 | |
| 2015-09-30 | $140.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $248.00K 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | $108.00K 10-Q · filed 2016-08-11 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-09 |